CT findings of pulmonary nocardiosis: a report of 9 cases

Abstract

Background

Pulmonary nocardiosis often occurs among immunocompromised patients, especially in those with impaired cell immunity related to AIDS and transplant. As the number of patients receiving transplant, the occurrence of pulmonary nocardiosis may also increase. Radiologic characteristics of this entity have not been well documented. In present study, CT findings of clinical confirmed pulmonary nocardiosis were retrospectively reviewed in order to understand CT features of pulmonary nocardiosis.

Methods

Electronic databases of Shenzhen People’s Hospital, Shenzhen, China, and the Third People’s Hospital of Longgang District, Shenzhen, China were searched for patients with definitive diagnosis of pulmonary nocardiosis and available CT images. Nine patients were founded and they were included in this retrospective analysis. Clinical presentations at diagnosis and related medical history were recorded. CT images were retrospectively reviewed by two radiologists in consensus.

Results

The patients consisted of seven men and two women with a median age of 47 years (range, 20–73 years). There were three immunocompromised patients and six immunocompetent patients. The latter included two patients had history of bronchiectasis. The symptoms at the diagnosis were nonspecific of fever, cough, sputum, dyspnea, chest pain, and hemoptysis. CT findings included: lung consolidation (n=8) with cavitation in three cases and foci of decreased enhancement in one patient who had contrast-enhanced CT, nodules/masses (n=6) with cavitation in two patients, ground-glass opacity (n=4), centrilobular nodules (n=4), pleural effusion (n=4), bronchiectasis (n=4), interlobular septal thickening (n=3), interlobular reticular opacity (n=3), lymph node enlargement (n=2), halo sign (n=2) and mucoid impaction (n=1).

Conclusions

Lung consolidation and nodules/masses are the most common findings, but CT findings of pulmonary nocardiosis are diverse and nonspecific. In some clinical background, such as immunocompromised patients or with some underlying lung diseases, consolidation or nodules/masses with cavitation may suggest the possibility of pulmonary nocardiosis.

Introduction

Nocardia is a genus of filamentous gram-positive, weakly acid fast, aerobic bacteria found in dust, soil, water, decaying vegetation, and stagnant matter (1). Lung infection can occur through direct inhalation of nocardia, which accounts for 73–77% of infected patients (2). Although pulmonary nocardiosis often occurs in immunocompromised patients, especially in those with impaired cell immunity related to AIDS and transplant, one-third of patients with nocardiosis have normal immunity (3,4).

Because its clinical presentations are nonspecific as subacute pneumonia, pulmonary nocardiosis is difficult to diagnose. If correct diagnosis can be obtained, pulmonary nocardiosis respond favorably to high-dose sulfonamide therapy, otherwise, hematogenous dissemination to soft tissue and brain is association with high morbidity and mortality (5-7). Therefore, prompt diagnosis and treatment is essential for improving patients’ outcome.

As the growing number of immunosuppressed patients, especially those with impaired cell-mediated immunity related to AIDS and transplant, infections of nocardia may increase also (8). In United States, nocardia infections occurred in about 22% of patients receiving organ transplant (9). Nocardia most often enters the hosts through respiratory tracts and produces infection in the lungs, although isolated brain soft tissue abscess have been reported (10). Imaging findings of pulmonary nocardiosis are not well documented. Only a few reports described CT findings of pulmonary nocardiosis, which were varied and nonspecific, including nodules/masses, ground-glass opacity, interlobular septal thickening, cavitation, and pleural effusion (9,11-15). Here we reported nine patients with pulmonary nocardiosis to evaluate its CT features.

Methods

Electronic databases of Shenzhen People’s Hospital, Shenzhen, China, and the Third People’s Hospital of Shenzhen Longgang District, Shenzhen, China, were searched for patients with definitive diagnosis of pulmonary nocardiosis and available CT images. This study was approved by the institutional review boards and the requirement for informed consent was waived due to its retrospective character. Clinical presentations at diagnosis and related medical history were recorded.

Thoracic CT examinations were performed at a Philips Brilliance 16 (Philips Medical Systems) or a Siemens SOMATOM Definition AS64 (Siemens Medical Solutions). The parameters were as follows: detector configuration, 16 mm × 1.5 mm or 64 mm × 0.625 mm; tube voltage, 120 to 140 kVp; tube current, 200 to 240 mA. Two sets of images were constructed: 5.0 mm slice thickness with 5.0 mm gap and 2.0 mm slice thickness with 1.0 mm gap. The latter was used for multiple planar reconstruction. Follow-up CT examinations were performed at seven patients. Contrast-enhanced CT was performed two patients. The CT images were evaluated by two radiologists in consensus on picture archiving and communication system (PACS).

Results

Patients demographics

The patients consisted of seven men and two women with a median age of 47 years (range, 20–73 years).There were three immunocompromised patients and six immunocompetent patients. Among the six immunocompetent patients, two patients had history of bronchiectasis. The symptoms at the diagnosis of pulmonary nocardiosis included fever (n=5) and cough (n=4), sputum (n=3), dyspnea (n=2), chest pain (n=2) and hemoptysis (n=2).

CT findings

All the nine patients had abnormalities on thoracic CT, which were summarized in Table 1. The most common CT findings were consolidation (n=8, 88.9%) and nodules/masses (n=6, 66.7%). Cavitation could be seen at consolidation in three cases (Figure 1) and at nodules/masses in two cases (Figure 2). Foci of decreased enhancement were noted at consolidation in one patient who had contrast-enhanced CT (Figure 3). Some CT features were illustrated in Figures 4-7. After a definitive diagnosis was obtained and prompt treatment, CT abnormalities in the seven patients who had follow-up CT were improved (disappeared or decreased) (Figure 8).

Table 1. CT findings of patients with pulmonary nocardiosis.

Variables	Case 1	Case 2	Case 3	Case 4	Case 5	Case 6	Case 7	Case 8	Case 9
Consolidation	(+)	(+)	(−)	(+)	(+)	(+)	(+)	(+)	(+)
Nodules/masses	(+)	(+)	(−)	(+)	(+)	(−)	(+)	(−)	(+)
Ground-glass opacity	(+)	(−)	(−)	(+)	(+)	(−)	(−)	(−)	(+)
Centrilobular nodules	(+)	(−)	(−)	(−)	(+)	(−)	(−)	(+)	(+)
Pleural effusion	(+)	(−)	(+)	(−)	(−)	(+)	(+)	(−)	(−)
Bronchiectasis	(+)	(−)	(−)	(−)	(+)	(−)	(−)	(+)	(+)
Interlobular septal thickening	(+)	(−)	(−)	(−)	(+)	(+)	(−)	(−)	(−)
Lymph node enlargement	(−)	(−)	(−)	(+)	(−)	(−)	(−)	(−)	(+)
Halo sign	(−)	(+)	(−)	(−)	(−)	(−)	(−)	(−)	(+)
Mucoid impaction	(−)	(−)	(−)	(+)	(−)	(−)	(−)	(−)	(−)

Figure 1.

Pulmonary nocardiosis in a 21-year-old immunocompetent male. Transverse CT image shows consolidations (long arrows), cavitation (star), nodules (short arrows) and pleural effusion (arrow head) in the right lung. Cavitation (star) can be seen in one consolidation.

Figure 2.

Pulmonary nocardiosis in a 21-year-old immunocompetent male. Coronal CT image shows multiple nodules (long arrows and short arrow). Cavitation can be seen in one nodule (short arrow).

Figure 3.

Pulmonary nocardiosis in a 58-year-old immunocompetent male. Transverse contrast-enhanced CT image shows a heterogeneous enhanced mass (arrow) with several low enhanced areas (arrows).

Figure 4.

Pulmonary nocardiosis in a 54-year-old immunocompetent female with 2-year-history of bronchiectasis. (A) Coronal CT image shows centrilobular nodules (circles) and bronchial wall thickening (arrows); (B) transverse contrast-enhanced CT image demonstrates lymph node enlargement (arrow).

Figure 5.

Pulmonary nocardiosis in a 47-year-old male with nasopharyngeal carcinoma. Transverse CT image shows mucoid impaction (arrows) and centrilobular nodules (circle).

Figure 6.

Pulmonary nocardiosis in a 46-year-old female with 20-year-history of bronchiectasis. Transverse CT image shows consolidations with bronchiectasis (long arrows) and bronchial wall thickening (short arrows).

Figure 7.

Pulmonary nocardiosis in a 73-year-old immunocompetent male. Transverse CT image shows a patchy consolidation (arrow) and interlobular reticular opacity (circle).

Figure 8.

Pulmonary nocardiosis in a 20-year-old male with nephritic syndrome and iatrogenic Cushing syndrome. (A) transverse CT image shows a consolidation (arrow) and pleural effusion (star); (B) transverse CT image of other slice shows a mass with halo sign (arrow); (C) transverse CT image at similar level of A after treatment show the consolidation (long arrow) on A decreased. A small patchy consolidation (short arrow) is noted also.

Discussion

Definitive diagnosis of pulmonary nocardiosis bases on histopathologic examination or culture. Unfortunately, difficulty in organism isolation and slow growth often retard prompt diagnosis. The clinicians often look for radiographic clues to the diagnosis of pulmonary nocardiosis. In the present nine-patient series, we found that the most common CT findings of pulmonary nocardiosis were lung consolidation and nodules/masses, followed by ground-glass opacity, centrilobular nodules, pleural effusion, bronchiectasis, interlobular septal thickening, interlobular reticular opacity, lymph node enlargement, halo sign and mucoid impaction. Cavitation or foci of decreased enhancement could be seen in consolidation and nodules/masses. To best of our knowledge, several findings, such as centrilobular nodules, interlobular reticular opacity, lymph node enlargement and mucoid impaction, had not been reported before. After treatment, the abnormalities showed disappeared or decreased.

Pulmonary nocardiosis is the most common type, which consists of 73–77% of nocardia infections (2). However, only several case reports deal with radiologic findings of pulmonary nocardiosis. Radiographic findings of pulmonary nocardiosis included consolidation with or without cavitation, nodules, pleural effusion, and chest wall extension, regardless of underlying etiology (16,17). High resolution CT (HRCT), which can depict lung structures and pathogenic changes with excellent details, is often used to evaluate pulmonary parenchyma and interstitial abnormalities (18-20). Comparing to conventional radiography, HRCT can detect pathologic changes of pulmonary nocardiosis at early phase and in better characteristics (5,6). In a pictorial review, Kanne et al. illustrated that CT findings of pulmonary nocardiosis included lung consolidation, nodules/masses, pleural involvement and chest wall extension (9). Oszoyoglu and colleagues reported the most common abnormalities on CT were nodules (71%) and cavitary lesions (43%) without any significant zonal or anatomic distribution in pulmonary nocardiosis after lung transplantation (13). Sato et al., respectively, analyzed HRCT of 18 patients with pulmonary nocardiosis (14). The most common findings were a nodule/mass (94.4%), ground-glass opacity (77.8%), interlobular septal thickening (77.8%), and cavitation (66.7%). What we had found in present series was similar to the literatures, but we also noted some abnormalities had not been reported before.

For nocardia spreads in respiratory tracts, colonizes there and causes bronchopneumonia. Pathological findings of bronchopneumonia consist of inflammatory changes in bronchial and bronchiolar walls, as well as exudation into adjacent alveoli. Therefore, bronchial wall thickening and centrilobular nodules are frequently found in patients with bronchopneumonia, sometimes forming tree-in-bud sign and mucoid impaction. Except bronchial wall thickening and interlobular septal thickening had reported before, centrilobular nodulars and mucoid impaction was not motioned in the literatures. In present series, centrilobular nodules and mucoid impaction were seen in four patients and one patient, respectively. Besides these two signs, interlobular reticular opacity and lymph node enlargement were not reported before. One explanation is that CT features of pulmonary nocardiosis has not been well documented and might be different in different areas or clinical background. Another reason perhaps is that other infections might be concurrent in these patients. Therefore, some abnormalities might result from other infections.

It was reported that preexisting structural lung diseases, such as bronchiectasis and pulmonary alveolar proteinosis, could increase the risk of nocardia colonization. In present series, there were two patients with history of bronchiectasis, and bronchiectasis was identified in four patients at the diagnosis of pulmonary nocardiosis. Therefore, some underlying lung pathological changes may provide colonizing sites for nocardia.

This retrospective study only included nine patients with pulmonary nocardiosis. The small sample size prevented to conclude specific radiographic clues for pulmonary nocardiosis and to compare CT findings between immunocompetent and immunocompromised patients. Another limitation of the study was that concurrent other infections were not excluded in all the patients. Therefore, some abnormalities might not result from nocardia infection in this series. Third, although we reported several CT findings firstly in pulmonary nocardiosis, histopathological correlation was not performed.

In summary, pulmonary nocardiosis can occur in both immunocompromised and immunocompetent patients. Lung consolidation and nodules/masses with or without cavitation are the most common findings, but CT findings of pulmonary nocardiosis are diverse and nonspecific. In some clinical background, such as immunocompromised patients or with some underlying lung diseases, consolidation or nodules/masses with cavitation may suggest the possibility of pulmonary nocardiosis. Acknowledge of CT findings can help radiologists to include pulmonary nocardiosis into differential diagnosis, and facilitate clinicians’ further diagnostic and treatment decision making, especially in those immunocompromised patients or with underlying diseases.

Ethical Statement: This study was approved by the institutional review boards and the requirement for informed consent was waived due to its retrospective character.